arrow_back Back to App

AMIGOS Act: Protecting IP and Prioritizing COVID-19 Vaccine Distribution

This act aims to restrict the waiver of intellectual property rights for COVID-19 vaccines without Congressional approval. It also sets priorities for distributing excess vaccines to other countries, focusing on Latin American nations and U.S. allies, with an emphasis on monitoring their distribution. Citizens may feel the impact through U.S. foreign public health policy.
Key points
The President cannot waive intellectual property protections for COVID-19 vaccines without explicit Congressional authorization.
Excess COVID-19 vaccines will be prioritized for countries in the Western Hemisphere with the lowest immunization rates, followed by U.S. allies.
Vaccines provided to foreign countries must be marked as U.S. assistance, unless it endangers delivery personnel or administration.
article Official text account_balance Process page
Expired
Citizen Poll
No votes cast
Additional Information
Print number: 117_HR_3236
Sponsor: Rep. Salazar, Maria Elvira [R-FL-27]
Process start date: 2021-05-14
Lustra uses Artificial Intelligence. Verify details in source documents.
Summarized by: gemini-2.5-flash-preview-05-20
Source data: api.congress.gov
AI work logs for this document launch

OFFICIAL LEGAL TITLE

AMIGOS Act

FREQUENTLY ASKED QUESTIONS

What is the official ID of this bill?

The official print number for this legislation is 117_HR_3236.

Which chamber initiated this legislation?

This legislation was initiated in the House of Representatives.

When did the legislative process begin?

The process officially started on 2021-05-14.

What are the main provisions?

Key points include:

  • The President cannot waive intellectual property protections for COVID-19 vaccines without explicit Congressional authorization.
  • Excess COVID-19 vaccines will be prioritized for countries in the Western Hemisphere with the lowest immunization rates, followed by U.S. allies.
  • Vaccines provided to foreign countries must be marked as U.S. assistance, unless it endangers delivery personnel or administration.
What is the specific legal status?

The current status is Expired.

Where can I read the full text of this legislation?

The full official text is available at: View full text

Who is the primary sponsor?

The primary sponsor is Rep. Salazar, Maria Elvira [R-FL-27].

What is the latest detailed status?

The latest detailed status is: Introduced in House

Is this summary verified?

Yes. This content was analyzed by AI and verified by the Lustra Judge System on 2025-12-27.

CATEGORIES

Health Economy